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1. Introduction 
Interferons comprise a heterogeneous group of 
(glyco)proteins which, in addition to other biological 
activities, by definition have antiviral properties 
(reviewed [l] ). 
Most of our knowledge concerning the heteroge- 
neity of interferon preparations has been obtained 
from studies of human interferon species. A classi- 
fication based mostly on its antigenic character is 
currently being used. So-called human type I inter- 
feron, induced by viruses and double-stranded poly- 
ribonucleotides, comprises two antigenically distinct 
interferon species: leukocyte (Le) interferon, pro- 
duced mainly by leukocytes and lymphoblastoid cell 
lines and fibroblast (F) interferon, formed mostly by 
fibroblast cell lines [2-41. 
The Le type contains at least two subspecies, dif- 
fering in size [5]; the F type seems to be homogene- 
ous in this respect [6]. The type of interferon pro- 
duced seems, besides on the cell type, also to be 
dependent on the mode of induction. Human fibro- 
blasts incubated with polyinosinic.polycytidylic acid 
(poly(I).poly(C)) produce only F interferon, how- 
ever, after induction with viruses also some Le inter- 
feron is formed [7]. Although data in [8] indicate 
that differences exist between various interferon prep- 
arations depending on the producer cell, our knowl- 
edge concerning the antigenic character of mouse 
interferon is limited. Here we present data on the 
antigenic character of two major components of 
mouse L cell interferon. 
2. Materials and methods 
2.1. Cell culture 
L-929 cells (Flow labs, Irvine, Scotland) were 
Elsevier/North-Holland Biomedical Press 
grown in monolayer in Eagle’s minimal essential 
medium (MEM) supplemented with 10% foetal calf 
serum, non-essential amino acids and gentamicin 
(80 ng/ml) at 37°C in a 5% COa atmosphere. Culture 
media were purchased from Flow labs. 
2.2. Interferon production 
Interferon was produced essentially as in [9]. Con- 
fluent monolayers of L-929 cells were incubated for 
6 h in MEM containing per ml, 20 ng poly(I).poly(C) 
(Miles labs, Elkhart, IN) and 0.8 mg diethylamino- 
ethyl (DEAE)-dextran (mol. wt 5 X lo5 ; Pharmacia, 
Uppsala). Next, cell layers were washed twice with 
MEM and incubated overnight in MEM. Subsequently, 
the culture fluid was collected, centrifuged for 15 
min at 1200 X g and concentrated by ultrafiltration 
(PM 10 filter, Amicon, Lexington, MA). Interferon 
solutions were dialyzed against phosphate-buffered 
saline (PBS0.02 M phosphate (pH 7.2), 0.15 M NaCl), 
filter sterilized and stored at -70°C. 
2.3. Geljiltration 
Interferon samples (1 ml in PBS) were layered on a 
Sephadex G-75 superfine column (2.6 X 35 cm, Phar- 
macia). Elution was carried out in PBS at 12 ml/h at 
4°C. Fractions (2 ml) were collected and assayed for 
interferon activity. Marker proteins (albumin 67 000, 
ovalbumin 45 000, chymotrypsinogen 25 000 and 
cytochrome c 12 500) were analyzed on the same 
column under identical experimental conditions. 
2.4. Preparation of anti-interferon sera 
Anti-interferon sera were prepared by monthly 
injections of New Zealand White rabbits with IO7 
units interferon (spec. act. lo6 units/mg protein). 
The first injection was mixed in Freund’s incomplete 
adjuvant (Difco, Detroit, MI), following injections, 
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starting 2 months after the first one, were without 
adjuvant. All samples were injected subcutaneously. 
About 1 week after each injection animals were bled, 
serum prepared, incubated for 30 min at 56°C and 
stored at -70°C. 
2 5. Interferon and anti-interferon assays 
Interferon activity was assayed on L-929 cells 
using vesicular stomatitis virus (VSV) as a challenge 
by essentially the method in [IO]. Titres are expressed 
in reference units/ml in terms of reference standard 
G-002-904-5 11. 
For assay of anti-interferon sera, serial dilutions of 
antiserum were incubated with appropriate amounts 
of interferon for 1 h at 37’C. Subsequently, samples 
were analyzed for antiviral activity on L-929 cells 
using VSV as a challenge as above. The neutralizing 
titre is expressed as the highest dilution of antiserum 
which is able to neutralize the antiviral activity of 
indicated amounts of interferon. 
3. Results and discussion 
Interferon was produced on L-929 cells, cultured 
in monolayer, by induction with poly(I).poly(C) 
and diethylaminoethyl (DEAE)-dextran. Poly(I) 




Fig.1. Gel filtration analysis of poly(I).poly(C)-induced 
mouse L cell interferon. 
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fraction number 
Fig.2. Gel filtration analysis of separated components of
poly(I).poly(C) induced mouse L cell interferon. Pooled 
fractions of Cl and C2 were analyzed on Sephadex G-75 
as in section 2. 
rated into at least two different compounds by sodi- 
um dodecyl sulfate-polyacrylamide gel electro- 
phoresis (SDS-PAGE) ([ 111, J. T. unpublished). 
These species have mol. wt -38 000 and 22 000, res- 
pectively. Besides SDS-PAGE we have also applied 
gel filtration under mild, non-dissociating conditions 
for analysis of poly(I).poly(C) interferon. We have 
chosen this procedure to be certain that no artificial 
modifications would be introduced during experi- 
Table 1 
The effect of anti-interferon sera on the antiviral activity of 
mouse L cell interferon components 
Interferon 
(units/ml) 
Type Neutralizing titre 
Serum 5 1254 Serum 5011-2 
40 Cl 3840 5120 
400 Cl 480 320 
40 c2 5120 <40 
400 c2 640 <40 
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mental handling. Under the conditions applied (PBS) 
the interferon preparation separates also into two 
major antiviral components. The apparent molecular 
weights observed here are somewhat higher than 
found by SDS-PAGE (48 000 (Cl) and 28 000 (C2), 
respectively) (fig.1). The components are present in 
-1: 1 molar ratio. The distinct mobility of both com- 
ponents was confirmed by re-analysis of pooled frac- 
tions of both molecular species under the same exper- 
imental conditions (fig.2). Both components were 
eluted from the column at the same position as found 
in the original preparation. 
For a further characterization we investigated the 
effect of different isolates of two antisera raised 
against the total interferon preparation. The antisera 
reacted in a completely different way in a neutraliza- 
tion assay with isolated Cl and C2. One of the anti- 
sera (5 125-4) was able to neutralize both the high and 
low molecular weight component (table 1). However, 
an early isolate of antiserum 5011 (501 l-2) showed a 
strong preference to Cl and had no neutralizing activ- 
ity against C2. Later isolates of this antiserum also 
neutralize C2 (J. T. in preparation). The data obtained 
with antiserum 501 l-2 implicate that there is a dif- 
ference in antigenic character between the two molec- 
ular species of poly(I).poly(C)-induced mouse 
L cell interferon. This is also further evidence that Cl 
is not a dimer of C2. Several explanations are possible 
for the finding that Cl and C2 react distinctly with 
antiserum 50 11-2. 
(i) It may be that Cl and C2 are completely dif- 
ferent molecules. 
(ii) It can be that C2 is a double-component of 
which one component is partially or completely 
different from Cl. 
(iii) Cl may be partially identical to C2 but also con- 
tain groups which are not present in C2 and that 
antiserum 501 l-2 is specific for these parts of 
the molecule. 
At this moment, based on antigenic studies alone, 
no firm conclusions can be drawn, Therefore it will 
be necessary to prepare antibodies against isolated Cl 
and C2 separately and investigate their cross-reactiv- 
ity. However, based on other studies, it is tempting 
to speculate that the third possibility is the correct 
one. 
Recent structural analyses [ 12,131 indicate that 
peptide maps and amino acid composition of both 
components of viral-induced mouse fibroblast inter- 
feron are closely related to each other. Furthermore, 
it has been shown that, concerning viral interferon, 
the high molecular weight component contains carbo- 
hydrate moieties, which are probably absent from the 
low molecular weight species [14,15]. It might be 
that besides differences in amino acid composition 
these differences in carbohydrate content play a role 
in the observed distinct antigenic properties of both 
components. 
However, it remains to be proven whether inter- 
feron synthesized by mouse fibroblasts and induced 
with poly(I).poly(C) is identical to viral-induced 
interferon or whether the same situation exists as in 
the human system, in which differences have been 
noticed. So far, both molecular weight analyses ([l 11, 
J. T. unpublished) and antigenic studies ([ 161, J. T. 
in preparation) show that both interferons are related 
to each other, but analysis by CH-Sepharose chro- 
matography [ 1 l] indicates differences between both 
preparations. Experiments are in progress to elucidate 
this problem. Moreover, it remains to be established 
whether there is any physiological significance for the 
occurrence of at least two molecular species of mouse 
fibroblast interferon. The observations described here 
may have important implications for further inter- 
feron investigations. Since it is now possible to char- 
acterize mouse interferon components by antigenic 
properties this can be a tool to identify interferons 
which have been produced by different cell types or 
have been separated by various chromatographic tech- 
niques. Moreover, specific antibodies can be used for 
purification of both components. 
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